An intracerebral hemorrhage (ICH) is bleeding that occurs directly inside the brain tissue when a blood vessel ruptures. It accounts for roughly 29% of all strokes worldwide and is the most dangerous type, with about one in three patients dying during their hospital stay. Unlike the more common ischemic stroke, which is caused by a blocked artery, ICH involves active bleeding that damages brain cells both from the initial burst and from the pressure the pooling blood creates inside the skull.
How Bleeding Damages the Brain
When a weakened blood vessel in the brain breaks open, blood rapidly collects into a mass called a hematoma. This clot of blood, platelets, and protein-rich fluid is denser than the surrounding brain tissue, and it physically crushes and displaces nearby brain cells. The damage doesn’t stop there. As the hematoma sits in the brain, it triggers a cascade of secondary injuries: rising pressure inside the skull distorts surrounding tissue, the protective barrier between the bloodstream and the brain breaks down, and inflammatory cells swarm into the area.
In many cases, the bleeding also expands after the initial rupture. Rather than a single burst, the hematoma can grow through what researchers describe as an “avalanche” effect, where the original bleed causes tiny secondary bleeds in the surrounding tissue. This expansion, which most commonly happens in the first few hours, is one of the main reasons early treatment is so critical.
What Causes a Blood Vessel to Rupture
The two most common causes are chronic high blood pressure and a condition called cerebral amyloid angiopathy, where a protein gradually weakens blood vessel walls in the brain. These two causes tend to produce bleeding in different locations. High blood pressure typically damages small arteries deep in the brain, particularly in a region called the basal ganglia. About 40% of hypertension-related hemorrhages occur there. Amyloid angiopathy, which becomes more common with age, tends to cause bleeding closer to the brain’s surface in the outer lobes.
Other causes include blood-thinning medications (both older drugs like warfarin and newer anticoagulants), abnormal tangles of blood vessels, brain tumors, cocaine or amphetamine use, and bleeding disorders. People taking blood thinners face a particular risk because their blood’s reduced ability to clot allows the hemorrhage to expand more easily.
Symptoms to Recognize
The hallmark of ICH is the sudden onset of neurological problems, and the specific symptoms depend on where in the brain the bleeding occurs. A hemorrhage on the left side of the brain might cause sudden difficulty speaking or weakness on the right side of the body, while bleeding in the back of the brain could affect vision or coordination.
Beyond these location-specific deficits, common symptoms include:
- Severe headache that comes on abruptly, often described as the worst headache of one’s life
- Nausea and vomiting
- Seizures
- Declining consciousness, ranging from confusion to complete unresponsiveness
If the blood breaks through into the brain’s fluid-filled chambers (the ventricles), it can block the normal flow of cerebrospinal fluid. This causes pressure to build rapidly, leading to worsening headache that’s worse when lying flat, double vision, and a dropping level of alertness. Blood pressure readings at the time of ICH are often extremely elevated, with diastolic pressure frequently above 110 mmHg.
How It’s Diagnosed
A non-contrast CT scan of the head is the primary tool for diagnosing ICH and is performed almost universally when someone arrives at the emergency department with stroke symptoms. Fresh blood appears as a bright white area against the darker gray of normal brain tissue, making it immediately visible. This scan takes only minutes and reliably distinguishes a hemorrhagic stroke from an ischemic one, a distinction that completely changes the course of treatment.
Additional imaging, such as CT angiography, may follow to look for the source of the bleeding, whether it’s an abnormal blood vessel, a tumor, or another structural cause. Doctors also use these scans to measure the volume of the hematoma in milliliters, which is one of the most important factors in deciding on treatment and predicting outcomes.
Treatment in the First Hours
The immediate priorities are stopping the bleeding from expanding, controlling blood pressure, and preventing the brain from swelling further. Current guidelines recommend lowering systolic blood pressure to around 140 mmHg, kept within a range of 130 to 150, to reduce the force driving additional bleeding without cutting off blood flow to vulnerable brain tissue.
For patients who were taking blood thinners when the hemorrhage occurred, reversing the medication’s effect as quickly as possible is essential. If a patient is on warfarin, the anticoagulant effect can be counteracted with vitamin K and clotting factor concentrates given through an IV. Newer blood thinners have their own reversal strategies; dabigatran, for example, has a specific antidote that can neutralize it rapidly.
When Surgery Is Considered
Whether the hematoma needs to be surgically removed depends largely on its size and the patient’s neurological condition. For smaller hematomas under about 30 milliliters, surgery generally isn’t recommended because the risks of the operation can outweigh the benefits, and patients tend to do at least as well with medical management alone. For hematomas of 60 milliliters or larger, surgical removal shows a clear survival benefit regardless of the patient’s other factors.
The gray zone falls between roughly 45 and 60 milliliters, where the decision depends on the individual. Surgeons weigh factors like how responsive the patient is, whether the pupils are reacting normally, the patient’s age, and other health conditions. Surgery may also be needed when the hematoma is causing dangerous brain shift or when fluid buildup in the ventricles can’t be controlled with other measures.
Survival and Long-Term Outlook
ICH carries the highest mortality of any stroke type. In a large population study of over 20,000 patients, 17.5% died within three days and 34.7% within 30 days. One-year mortality reached 45.4%, and by five years, 61.8% of patients had died. These numbers are sobering, but they represent averages across all severities, including the largest and most devastating hemorrhages.
Doctors estimate individual prognosis using a scoring system that weighs five factors: the patient’s level of consciousness (the single strongest predictor), the volume of the hematoma, whether blood has entered the ventricles, whether the bleeding originated in the lower part of the brain, and whether the patient is 80 or older. A person who is alert with a small, contained bleed has a vastly different outlook than someone who is comatose with a large hemorrhage that has spread into the ventricles.
Recovery and Rehabilitation
Survivors of ICH typically face a long rehabilitation process. The deficits left behind depend entirely on which part of the brain was damaged and how much tissue was affected. Common challenges include one-sided weakness or paralysis, difficulty with speech or language, problems with balance and coordination, cognitive changes like difficulty with memory or attention, and emotional shifts including depression.
Rehabilitation usually begins in the hospital as soon as the patient is medically stable and continues for months, sometimes years. It typically involves physical therapy to rebuild strength and mobility, occupational therapy to relearn daily tasks, and speech therapy if language or swallowing has been affected. Recovery is most rapid in the first three to six months, though meaningful improvement can continue well beyond that window. The brain’s ability to reroute functions around the damaged area varies considerably from person to person, making individual outcomes difficult to predict early on.
Preventing a second hemorrhage is a major focus after recovery. For people whose ICH was driven by high blood pressure, consistent blood pressure control is the single most important step. For those with amyloid angiopathy, avoiding blood-thinning medications when possible reduces the risk of recurrence. Lifestyle factors like limiting alcohol, avoiding stimulant drugs, and staying physically active also play a role in long-term prevention.